Cambridge, UK: Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines, today announced the formal appointment of Dr. Ian Gilham as Chairman of its Board of Directors. Dr. Gilham’s healthcare industry career spans thirty years encompassing all aspects of successful company growth and development. Dr. Gilham was Chief […]
From: Tanya Samazan [mailto:tsamazan@strategic-directions.com] Agreement supports further development of organoids as next-generation drug screening platform Utrecht,- The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture […]
MADISON, WISCONSIN — Promega Corporation announces ViaFect™ Transfection Reagent, a tool for efficient DNA transfer into a wide variety of cell lines, including challenging suspension cells and stem cell-derived lines. ViaFect Transfection Reagent allows researchers to develop transfection-based assays in the cell line most relevant for their biology of interest. Induced pluripotent stem cell (iPSC)-derived […]
GAITHERSBURG, Md. –MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will be leading a series of events at Cambridge Healthtech Institute’s 13th Annual PepTalk to be held January 13-17, 2014, in Palm Springs, CA. The highlighted event will be the introduction of the 2014 MaxCyte STX® Scalable Transfection System, a smaller footprint version […]
MADISON, WIS. – Cellular Dynamics International (CDI; Nasdaq: ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health Sciences SA (NIHS).Terms of the agreement were not disclosed. CDI’s iCell® product line includes cardiomyocytes, neurons, hepatocytes, and endothelial cells, with numerous other cell types in development. The company’s MyCell® Products are cell […]
HOLLISTON, Mass. — Humans have always organized things. Something in our brains tells us to break information into smaller chunks, making it easier to understand. We separate animals into different species, books into genres and clothing into styles. In this era of endless medical specialization, our aptitude for grouping is more important than ever. For […]
Paris – Cellectis (Alternext: ALCLS), the genome engineering specialist, has announced the completion of a structurally important transaction concerning its subsidiary Cellectis bioresearch, which specializes in designing, developing and marketing products and services essentially for academic and biopharmaceutical industry researchers: a simplified legal structure, with Ectycell merged into Cellectis bioresearch; and a reinforced equity position, […]
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts. Using AMSBIO stable cell lines not only provides an optimized solution for manufacture of therapeutic and diagnostic protein, but also for applications in drug screening, […]
WALTHAM, Mass. — Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company (NYSE: GE), for approximately $1.06 billion. The businesses will become part […]
CHALFONT ST. GILES, UK – GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses for approximately $1.06 billion. The acquisition will allow GE to expand its offering of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
